OXY
42
17
GOOG
77
14
FMC
23
7
CLX
65
2
NDAQ
46
2
LB
16
9
DFS
64
4
GRMN
53
3
SIG
52
5
EA
41
3
PEP
33
4
MAC
53
5
UPS
51
6
XOM
33
3
CRM
65
6
MAR
57
3
CFG
36
12
ADT
12
2
UNP
38
5
GWW
50
9
OXY
42
17
GOOG
77
14
FMC
23
7
CLX
65
2
NDAQ
46
2
LB
16
9
DFS
64
4
GRMN
53
3
SIG
52
5
EA
41
3
PEP
33
4
MAC
53
5
UPS
51
6
XOM
33
3
CRM
65
6
MAR
57
3
CFG
36
12
ADT
12
2
UNP
38
5
GWW
50
9
Financhill
Back

ProPhase Labs Vs. Novo Nordisk AS Industry Stock Comparison

Sell
10

PRPH
ProPhase Labs

Last Price:
$0.63
Seasonality Move:
15.03%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
10
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.61. The Score for PRPH is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 24.33 Sell
Chaikin Money Flow: -319202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.67 - 0.77) Sell
Bollinger Bands (100): (1.12 - 2.76) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 0.71 Sell
50-day SMA: 1.34 Sell
200-day SMA: 3.4 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.77 Sell
50-day EMA: 1.23 Sell
200-day EMA: 2.93 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):